Ipamorelin

  • CasNo:170851-70-4
  • Molecular Formula:C38H49N9O5
  • Purity:
  • Molecular Weight:
Inquiry

Product Details

170851-70-4 Name

Name

Ipamorelin

Synonym

IpoMarelin;IpaMorelin Acetate;Aib-His-D-2-Nal-D-Phe-Lys-NH2;IPAMORELIN(1MG);IPAMORELIN(5MG);2-Methylalanyl-L-histidyl-3-(2-naphthyl)-D-alanyl-D-phenylalanyl-L-lysinamide;L-Lysinamide,2-methylalanyl-L-histidyl-3-(2-naphthalenyl)-D-alanyl-D-phenylalanyl-;NNC-26-0161

 

170851-70-4 Chemical & Physical Properties

Melting point 

44-147°C

Boiling point

1185.5±65.0 °C at 760 mmHg

Density

1.3±0.1 g/cm3

Molecular Formula

C38H49N9O5

Molecular Weight

711.853

Flash Point

670.7±34.3 °C

PSA

240.21000

LogP

1.72

Exact Mass

711.385681

Vapour Pressure

0.0±0.3 mmHg at 25°C

Index of Refraction

1.624

storage temp. 

-20°C Freezer

solubility 

Acetonitrile (Slightly, Heated), Methanol (Very Slightly), Water (Slightly)

 

170851-70-4 Description

Ipamorelin (INN) (developmental code name NNC 26-0161) is a peptide selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS) and a growth hormone secretagogue.It is a pentapeptide with the amino acid sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2 that was derived from GHRP-1.

 

170851-70-4 Uses

  1. Ipamorelin was originally developed by Novo Nordisk, and was investigated in phase II clinical trials by Helsinn Therapeutics for the treatment of postoperative ileus, but was discontinued due to lack of efficacy.Ipamorelin has been used by athletes as a performance enhancing drug.
  2. Ipamorelin is a metabolite of growth hormone releasing peptides (GHRPs). Ipamorelin is a pentapeptide with strong growth hormone releasing potency that evokes insulin release from pancrease of normal and diabetic rats.